Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
C-Met and its gene product Met have been extensively studied in terms of their relevance to cancer biology. Activation of Met via autocrine, paracrine, or mutational mechanisms can lead to tumorigenesis and metastasis. Numerous studies have linked inappropriate expression of this ligand-receptor pair to most types of human solid tumors, including those of brain, breast, ovary, thyroid, pancreas, stomach, prostate, and nasopharyngeal carcinoma.Clinical applications of a Met binding peptide (MET-PEP) as a diagnostic reagent and therapeutic vector can be sought.